Related Experiment Videos
Summary
Myelography accurately diagnoses spinal cord compression in breast cancer patients. However, prognosis remains poor, with no survival difference between patients with or without myelographic evidence of cord compression.
Area of Science:
- Oncology
- Neurology
- Radiology
Background:
- Spinal cord compression is a serious complication in patients with metastatic breast cancer.
- Early and accurate diagnosis is crucial for timely management and potentially improving outcomes.
Purpose of the Study:
- To evaluate the diagnostic accuracy of myelography in detecting spinal cord lesions in breast cancer patients.
- To correlate myelographic findings with clinical symptoms, imaging results, and patient prognosis.
Main Methods:
- Myelography was performed on 78 breast cancer patients presenting with symptoms suggestive of spinal cord compression.
- Clinical signs, symptoms, cerebrospinal fluid (CSF) analysis, bone scans, and skeletal x-rays were correlated with myelographic results.
- Treatment response and survival rates were analyzed in relation to myelographic findings and disease burden.
Main Results:
- Myelography identified extradural defects in 54% of patients, with 50% of these showing a complete block.
- Positive myelograms (M+) correlated strongly with positive bone scans (100%) and skeletal x-rays (97%).
- Clinical symptoms like back pain and bladder/bowel dysfunction were more frequent in M+ patients, though not highly specific for cord lesions.
Conclusions:
- Myelography is the most precise diagnostic tool for spinal cord lesions in breast cancer patients.
- Despite accurate diagnosis, the overall prognosis for metastatic breast cancer with spinal cord compression is poor.
- Treatment response is influenced by metastatic burden and time from diagnosis, but survival is not significantly impacted by myelographic findings.